SGN-STNV for Non-Small Cell Lung Cancer

Phase-Based Progress Estimates
Non-Small Cell Lung Cancer+11 MoreSGN-STNV - Drug
All Sexes
What conditions do you have?

Study Summary

This trial will test the safety and effectiveness of the drug SGN-STNV for treating solid tumors.

Eligible Conditions
  • Non-Small Cell Lung Cancer
  • Cervical Cancer
  • HER2 Negative Breast Cancer
  • Esophageal Cancer
  • Pseudomyxoma Peritonei
  • Colorectal Cancer
  • Stomach Tumors
  • Pancreatic Cancer
  • Ovarian Tumors
  • Endometrial Cancer
  • Gastroesophageal Junction Cancer
  • Appendiceal Adenocarcinoma

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

3 Primary · 9 Secondary · Reporting Duration: Up to approximately 3 years

Year 3
Area under the concentration-time curve (AUC)
Incidence of adverse events (AEs)
Incidence of antidrug antibodies (ADA)
Incidence of laboratory abnormalities
Maximum concentration (Cmax)
Time to maximum concentration (Tmax)
Trough concentration (Ctrough)
Up to 28 days
Incidence of dose limiting toxicities
Year 3
Duration of objective response (DOR)
Objective response rate (ORR) as assessed by the investigator per RECIST v1.1
Overall survival (OS)
Progression-free survival (PFS)

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

1 of 1

Experimental Treatment

315 Total Participants · 1 Treatment Group

Primary Treatment: SGN-STNV · No Placebo Group · Phase 1

Experimental Group · 1 Intervention: SGN-STNV · Intervention Types: Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to approximately 3 years

Who is running the clinical trial?

Seagen Inc.Lead Sponsor
185 Previous Clinical Trials
61,264 Total Patients Enrolled
Suzanne McGoldrick, MDStudy DirectorSeagen Inc.
1 Previous Clinical Trials
285 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 10 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have a disease indication.
You have esophageal cancer.
You have a diagnosis of either gastric cancer or GEJ carcinoma.

Who else is applying?

How old are they?
What portion of applicants met pre-screening criteria?
Did not meet criteria100.0%